These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2516481)

  • 1. [The hormonal profile in the polycystic ovary syndrome].
    Donát J; Kohoutek M; Donátová N; Lacinová V
    Cesk Gynekol; 1989 Nov; 54(9):684-8. PubMed ID: 2516481
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal correlations in the polycystic ovary syndrome.
    Messina M; Milani P; Gentile L
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 4. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
    La Marca A; Orvieto R; Giulini S; Jasonni VM; Volpe A; De Leo V
    Fertil Steril; 2004 Oct; 82(4):970-2. PubMed ID: 15482785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stein-Leventhal syndrome. Personal cases].
    Rapino P; Sabatino P; Della Lunga S; Marulli R
    Minerva Med; 1982 Oct; 73(40):2793-800. PubMed ID: 6813772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ovarian wedge resection for polycystic ovary syndrome: analysis of 28 cases].
    Zhu RL
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):290-3, 319. PubMed ID: 3936686
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
    Evron S; Yosef SM; Schenker JG; Diamant YZ
    Isr J Med Sci; 1984 Jul; 20(7):630-3. PubMed ID: 6432730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relations between polycystic ovary and idiopathic hirsutism].
    Montesanti F; Rama GP; Francia G; Adami S; Lo Cascio V
    G Clin Med; 1988 Mar; 69(3):183-5. PubMed ID: 2971587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperthecosis and endocrinological study].
    Nagai K; Ohshige T; Sakata M; Koike H; Mori N; Miyakawa I
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):365-8. PubMed ID: 2113560
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
    Vulkov I
    Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Somatomedin and somatostatin in polycystic ovary syndrome].
    Huber JC
    Gynakol Rundsch; 1991; 31 Suppl 2():66-8. PubMed ID: 1686431
    [No Abstract]   [Full Text] [Related]  

  • 17. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC; Ertunc D; Evruke C; Dilek S
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum AMH, FSH, and LH levels in PCOS.
    Georgopoulos NA; Saltamavros AD; Decavalas G; Piouka A; Katsikis I; Panidis D
    Fertil Steril; 2010 Feb; 93(3):e13; author reply e14. PubMed ID: 20060523
    [No Abstract]   [Full Text] [Related]  

  • 19. [Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].
    Brailly-Tabard S; Trabado S; Khallouf O
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S329-33. PubMed ID: 19268210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.